Clinical Trial Update: A Phase 2 Study of JADE101 in Participants With Immunoglobulin A Nephropathy [Phase 2]

View source ↗

Summary

A Phase 2 study of JADE101 for IgA nephropathy is listed, but the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• JADE101

Snippet

Sponsor: Jade Biosciences, Inc. | Conditions: IgA Nephropathy | Phase 2 | Status: NOT_YET_RECRUITING